BLACK WEEKSFlakonai −15% · rinkiniai −10% · kita −5%su koduNemokamas siuntimas Vokietijoje nuo €200

Šis puslapis išverstas automatiškai ir jame gali būti klaidų. Ar lietuvių kalba yra jūsų gimtoji? Mielai sulauksime jūsų atsiliepimų ir pataisymų.Siųsti atsiliepimą

The Peptide Desk The Peptide Desk
Semaglutide, produkto nuotrauka

Laboratorijos ataskaita

PDF
99%
Grynumas
Ištirta
Semaglutide 10mg
Laboratorija
Analiza Białek
Data
October 2026
Rezultatas
99% purity (10.30 mg measured)
Endotoksinai
5.83 EU/vial
Užsakymo nr.
Slaptažodis

Ištirta nepriklausomai, su slaptažodžiu galima patikrinti tiesiogiai laboratorijoje.

GLP-1

Semaglutide

GLP-1

Užsakymas

Vieneto kaina - Nemokamas siuntimas Vokietijoje nuo 200 € Black Weeks metu
  • DHL su sekimu
  • Diskreti pakuotė

4.6 iš 5 TrustpilotAtsiliepimų: 73

Taip pat ieškoma kaip: Semaglutid · Sema

Taip pat yra tabletėmis: Semaglutide Oral →

Trumpai

Semaglutide skaičiais

Pagrindiniai rodikliai iš mūsų žinyno. Vilkite tašką kreive, kad pamatytumėte, kiek lieka po vienos dozės, pagal skaičiavimą.

Visas žinyno įrašas

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~7 days

Half-life ~7 days
After 14 days: 25 %
Day 750 %Day 1425 %Day 2112.5 %Day 353.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

~7days

Class
GLP-1 agonistsingle
Frequency
Once weeklysubcutaneous
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 50 mg6 sizes in the shop
  1. ~15 %

    Phase 3 study in obesity (STEP 1, ~15% weight reduction at 68 weeks) (opens in a new tab)

    Wilding et al., New England Journal of Medicine, 2021
  2. Cardiovascular study in obesity without diabetes (SELECT) (opens in a new tab)

    Lincoff et al., New England Journal of Medicine, 2023
  3. Cardiovascular study in type 2 diabetes (SUSTAIN-6) (opens in a new tab)

    Marso et al., New England Journal of Medicine, 2016

Žinios

Viskas apie Semaglutide

Išsami informacija netrukus.

Pravers

Ko dar jums reikės

Bakteriostatinis vanduo į krepšelį pridedamas automatiškai. Švirkštai ir servetėlės - vienu paspaudimu.

Insulino švirkštai

10 vnt. · 5.50 €

Spiritinės servetėlės

50 vnt. · 10 €

Kiek vandens?

Vienetai ant švirkšto jūsų flakono dydžiui.

Atidaryti skaičiuoklę →

FAQ

Dažnai užduodami klausimai

Šaltiniai kiekvienam atsakymui: žinyno įrašas

Dar turite klausimų?

Parašykite mums, mūsų komanda jums padės.

Is Semaglutide approved?

Yes. ChEMBL lists Semaglutide with phase 4 as the highest phase and a first approval in 2017. As an injection it is given once a week, there is also a tablet (separate entry). The information here describes the state of research and is not a recommendation for use.

How does Semaglutide differ from Tirzepatide and Retatrutide?

The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide also on GIP, Retatrutide additionally on the glucagon receptor. In return Semaglutide has the longest series of trials in the group, with large outcome trials on heart, kidney and liver.

What did the weight trials show?

In STEP 1 weight fell by 14.9 percent on average after 68 weeks, by 2.4 percent on placebo. Half of the participants lost at least 15 percent. In STEP 4 those who switched to placebo after 20 weeks regained weight: 6.9 percent by week 68, while the other group lost a further 7.9 percent.

What is known about heart, kidney and liver?

In SELECT (cardiovascular disease, overweight without diabetes) there were 6.5 versus 8.0 percent major cardiovascular events. In FLOW (type 2 diabetes with kidney disease) the risk of major kidney events was 24 percent lower. In ESSENCE MASH resolved after 72 weeks in 62.9 percent, in 34.3 percent on placebo.

How high were the doses in trials?

The highest study dose was 16 mg per week in a phase 2 trial in type 2 diabetes. Compared with the lowest dose there, blood sugar fell barely more, weight somewhat more, but there were more side effects and discontinuations. In STEP UP a higher dose also brought more weight loss and more complaints. The entry describes the opposite as a principle: start low and only increase until an effect is noticeable. This is not a dosing recommendation.

Which side effects were seen?

Most often nausea and diarrhoea, mostly transient and mild to moderate. In STEP 1 4.5 percent stopped because of gastrointestinal effects, 0.8 percent on placebo. In SUSTAIN-6 complications of the retina occurred more often in type 2 diabetes. With the higher dose from STEP UP altered skin sensations were more common.

How long does Semaglutide stay in the body?

According to the label the half-life is about one week, Semaglutide is still in the blood for about five weeks after the last dose. More than 99 percent is bound to the blood protein albumin. A steady level is reached after four to five weeks of weekly dosing.

Palyginimai

Kuo skiriasi

Susiję

Susiję produktai